Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-27
2008-05-27
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S526000, C540S527000
Reexamination Certificate
active
10565700
ABSTRACT:
This invention relates to certain substituted lactam compounds of the formula (I), particularly caprolactam compounds, which are useful for the treatment of cancer
REFERENCES:
patent: WO00/29382 (2000-05-01), None
patent: WO01/85697 (2001-11-01), None
patent: WO02/39990 (2002-05-01), None
Boeckman, Robert et al., “Synthesis of bengamides via polyol intermediate”, Helvetica Chimica Acta, vol. 85, pp. 4532-4560, 2002.
Kinder, Frederick et al., “Synthesis and antitumour activity of ester modified analogues of bengamide B”, J. Med. Chem, vol. 44, pp. 3692-3699, 2001.
Bair Kenneth Walter
Kinder, Jr. Frederick Ray
Versace Richard William
Kifle Bruck
Novartis AG
LandOfFree
Substituted lactams and their use as anti-cancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted lactams and their use as anti-cancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted lactams and their use as anti-cancer agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3931850